Genenta Science S.p.A. (GNTA:NASDAQ) closed at $0.669 on October 15, 2026, up 1.39% on the day. The stock trades 93.3% below its 52-week high of $10.00 and 21.7% above its 52-week low of $0.550. Over the past year, it lost 79.4%. Genenta Science S.p.A. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -13.12% | -20.46% | -57.41% | -5.82% | -79.37% |
In 252 trading sessions since October 14, 2025, GNTA closed higher on 100 days (40%). Its best day was October 24, 2025 (+91.95%) and its worst was October 27, 2025 (-46.45%). The stock moved 10% or more in a single session 37 times. It opened at least 5% above the previous day's high 10 times.
Genenta Science SPA is a clinical-stage biotechnology company pioneering the development of lentivirus-based first-in-class gene and cell therapies in cancer.
Find more stocks like GNTA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.